Is Kromek Group (LSE:KMK) Strengthening Its Role in the UK Defence and Medical Technology Space?

3 min read | July 21, 2025 10:11 AM BST | By Team Kalkine Media

Highlights

  • Kromek Group develops advanced radiation detection systems for defence and medical use.

  • Multi-year agreements secured across imaging, homeland security, and nuclear detection segments.

  • UK and US facilities support in-house design, development, and supply chain operations.

Kromek Group (LSE:KMK) operates within the UK’s defence and medical technology sector, delivering radiation detection solutions based on cadmium zinc telluride (CZT) technology. Its systems are applied in high-precision fields such as nuclear threat identification, advanced medical diagnostics, and critical infrastructure protection.

Headquartered in the UK and operating additional facilities in the United States, the company supports full-cycle development, from design to manufacturing. Its client base includes public institutions and international commercial firms requiring high-resolution identification of radioactive isotopes.

New Contract Engagements Across Core Applications

The company has secured a range of new contracts focused on its detector solutions. Among them is a multi-year supply arrangement with a global medical imaging equipment provider, centred on the use of CZT-based modules for gamma imaging.

In the defence sector, Kromek entered into an agreement with a government department to supply radiation detection products intended for use in homeland protection initiatives. This work is structured under a multi-phase contract with repeat delivery milestones.

A separate US defence agency also extended its engagement with the group, continuing support for field detection technologies. The contract reinforces the company’s presence in government-driven radiation monitoring programmes.

Production Infrastructure and Operational Expansion

To address growing demand, the company increased its production capabilities at both its UK and US facilities. These sites are equipped to handle design, prototyping, and manufacturing of complex detection units and electronics.

Investments were directed toward automated manufacturing lines, expanded cleanroom space, and specialised testing equipment. This infrastructure supports consistent product standards and tailored system configuration based on user requirements.

The group's vertically integrated approach allows for more agile response to contract specifications and delivery schedules. ASIC development remains part of its hardware suite, optimising signal processing performance in medical and security deployments.

Portfolio Deployment Across Medical, Security, and Industrial Markets

Kromek’s products are used in a variety of sectors. In medical imaging, its detectors contribute to diagnostic systems used in hospitals and clinical centres. These products enable clearer imaging at lower doses, increasing application efficiency.

For nuclear security and industrial use, the company provides both handheld and stationary detectors. These solutions assist in radiation mapping, contamination monitoring, and regulatory compliance within energy facilities.

Security products include compact and wearable devices for first responders, capable of identifying a broad spectrum of isotopes. The company is also advancing solutions integrated with drones for airborne detection and response.

Global Reach and Client Network Development

The firm’s customer portfolio includes commercial enterprises, research institutes, and public-sector agencies across North America, Europe, and Asia-Pacific. Contract structures often span several years, allowing for repeat delivery and ongoing product support.

Client engagements typically begin with prototype demonstrations, followed by phased rollouts. The company participates in major global technology exhibitions and trade forums, helping expand its international footprint and foster strategic collaboration. Kromek continues to align its development roadmap with partner requirements, maintaining dialogue through technical workshops and product training programmes.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next